Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 27.60B | 33.46B | 25.39B | 22.77B | 21.91B | 18.50B |
Gross Profit | 9.71B | 15.72B | 10.62B | 9.09B | 8.65B | 7.45B |
EBITDA | 3.46B | 3.14B | 6.51B | 2.14B | 2.83B | 2.97B |
Net Income | 1.18B | 557.53M | 3.57B | 447.69M | 1.30B | 1.41B |
Balance Sheet | ||||||
Total Assets | 0.00 | 97.31B | 23.55B | 23.92B | 23.69B | 20.03B |
Cash, Cash Equivalents and Short-Term Investments | 1.79B | 19.16B | 539.32M | 371.99M | 253.16M | 159.77M |
Total Debt | 0.00 | 23.78B | 4.67B | 8.29B | 8.23B | 6.18B |
Total Liabilities | -12.12B | 56.92B | 12.06B | 15.64B | 15.36B | 12.60B |
Stockholders Equity | 12.12B | 34.40B | 11.49B | 8.28B | 8.33B | 7.44B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -575.29M | 1.15B | 946.46M | -1.32B | -1.04B |
Operating Cash Flow | 0.00 | 370.37M | 1.93B | 2.87B | 1.78B | 1.65B |
Investing Cash Flow | 0.00 | -15.48B | 2.79B | -1.89B | -3.07B | -2.66B |
Financing Cash Flow | 0.00 | 25.96B | -4.46B | -1.03B | 1.38B | 1.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | ₹107.22B | 57.88 | 0.48% | 10.29% | 26.09% | ||
64 Neutral | ₹84.12B | 53.42 | 0.58% | -6.59% | -41.72% | ||
64 Neutral | ₹120.83B | 98.17 | 0.07% | 24.37% | 29.89% | ||
63 Neutral | ₹70.30B | 41.12 | 0.70% | 7.10% | 29.32% | ||
62 Neutral | $10.28B | 6.21 | 0.76% | 2.84% | 3.10% | -36.03% | |
55 Neutral | ₹87.12B | 40.77 | 0.22% | 21.50% | 78.82% | ||
52 Neutral | ₹112.17B | 63.44 | 0.32% | 31.78% | -84.27% |
Sudarshan Chemical Industries Limited announced the publication of its audited financial results for the quarter and year ending March 31, 2025, in major newspapers. This disclosure is part of the company’s compliance with SEBI regulations, reflecting its commitment to transparency and accountability to its stakeholders.